+

WO2001096526A3 - Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide - Google Patents

Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide Download PDF

Info

Publication number
WO2001096526A3
WO2001096526A3 PCT/CN2001/000906 CN0100906W WO0196526A3 WO 2001096526 A3 WO2001096526 A3 WO 2001096526A3 CN 0100906 W CN0100906 W CN 0100906W WO 0196526 A3 WO0196526 A3 WO 0196526A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
tumor suppressor
human tumor
suppressor factor
Prior art date
Application number
PCT/CN2001/000906
Other languages
English (en)
Chinese (zh)
Other versions
WO2001096526A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Shanghai Biowindow Gene Dev
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Dev, Yumin Mao, Yi Xie filed Critical Shanghai Biowindow Gene Dev
Priority to AU89515/01A priority Critical patent/AU8951501A/en
Publication of WO2001096526A2 publication Critical patent/WO2001096526A2/fr
Publication of WO2001096526A3 publication Critical patent/WO2001096526A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un nouveau polypeptide, un facteur humain 11.77 d'inhibition tumorale, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de toutes sortes de tumeurs. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant le facteur humain 11.77 d'inhibition tumorale.
PCT/CN2001/000906 2000-06-07 2001-06-04 Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide WO2001096526A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU89515/01A AU8951501A (en) 2000-06-07 2001-06-04 A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 00116365 CN1326977A (zh) 2000-06-07 2000-06-07 一种新的多肽——人肿瘤抑制基因11.77和编码这种多肽的多核苷酸
CN00116365.5 2000-06-07

Publications (2)

Publication Number Publication Date
WO2001096526A2 WO2001096526A2 (fr) 2001-12-20
WO2001096526A3 true WO2001096526A3 (fr) 2002-05-10

Family

ID=4585769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000906 WO2001096526A2 (fr) 2000-06-07 2001-06-04 Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide

Country Status (3)

Country Link
CN (1) CN1326977A (fr)
AU (1) AU8951501A (fr)
WO (1) WO2001096526A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7050456B1 (en) 1998-12-04 2006-05-23 Tekelec Methods and systems for communicating signaling system 7 (SS7) user part messages among SS7 signaling points (SPs) and internet protocol (IP) nodes using signal transfer points (STPs)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013436A (en) * 1994-07-08 2000-01-11 Visible Genetics, Inc. Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013436A (en) * 1994-07-08 2000-01-11 Visible Genetics, Inc. Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene

Also Published As

Publication number Publication date
AU8951501A (en) 2001-12-24
WO2001096526A2 (fr) 2001-12-20
CN1326977A (zh) 2001-12-19

Similar Documents

Publication Publication Date Title
WO2001096526A3 (fr) Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide
WO2002008421A1 (fr) Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide
WO2001096524A3 (fr) Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide
WO2002000824A3 (fr) Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075043A3 (fr) Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2002000828A3 (fr) Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001094533A3 (fr) Nouveau polypeptide, proteine humaine 13 de regulation de la proteine phosphorylase, et polynucleotide codant ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide
WO2001075056A3 (fr) Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075023A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide
WO2001064866A1 (fr) Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide
WO2001075057A3 (fr) Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载